62.49 1.03 (1.68%)
198.9K XNAS Volume
XNAS 14 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Krista Davis | SVP, CHIEF HR OFFICER | Sale of securities on an exchange or to another person at price $ 60.86 per share. | 07 Mar 2025 | 1,000 | 66,525 (0%) | 0% | 60.9 | 60,860 | Common Stock |
| Ori Gutwerg | SVP, GENERICS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 300 | 13,204 | - | - | Stock Option (right to buy) | |
| Ori Gutwerg | SVP, GENERICS | Sale of securities on an exchange or to another person at price $ 60.03 per share. | 05 Mar 2025 | 300 | 99,176 (0%) | 0% | 60.0 | 18,009 | Common Stock |
| Ori Gutwerg | SVP, GENERICS | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 05 Mar 2025 | 5,084 | 94,092 (0%) | 0% | 60 | 305,040 | Common Stock |
| Ori Gutwerg | SVP, GENERICS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.49 per share. | 05 Mar 2025 | 300 | 99,476 (0%) | 0% | 31.5 | 9,447 | Common Stock |
| Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.89 per share. | 28 Feb 2025 | 1,570 | 99,176 (0%) | 0% | 61.9 | 97,167 | Common Stock |
| Thomas Rowland | SVP, HEAD - ESTABLISHED BRANDS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.89 per share. | 28 Feb 2025 | 627 | 45,465 (0%) | 0% | 61.9 | 38,805 | Common Stock |
| Stephen P. Carey | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.89 per share. | 28 Feb 2025 | 1,861 | 192,223 (1%) | 0% | 61.9 | 115,177 | Common Stock |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.89 per share. | 28 Feb 2025 | 12,216 | 502,694 (4%) | 0% | 61.9 | 756,048 | Common Stock |
| Christopher Mutz | HEAD OF RARE DISEASE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.89 per share. | 28 Feb 2025 | 1,275 | 114,191 (0%) | 0% | 61.9 | 78,910 | Common Stock |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.89 per share. | 28 Feb 2025 | 1,099 | 80,945 (0%) | 0% | 61.9 | 68,017 | Common Stock |
| Krista Davis | SVP, CHIEF HR OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.89 per share. | 28 Feb 2025 | 1,099 | 67,525 (0%) | 0% | 61.9 | 68,017 | Common Stock |
| Krista Davis | SVP, CHIEF HR OFFICER | Sale of securities on an exchange or to another person at price $ 60.20 per share. | 21 Feb 2025 | 1,000 | 68,624 (0%) | 0% | 60.2 | 60,200 | Common Stock |
| Christopher Mutz | HEAD OF RARE DISEASE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 16,538 | 118,123 (0%) | 0% | 0 | Common Stock | |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 14,362 | 83,014 (0%) | 0% | 0 | Common Stock | |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 60,932 | 522,709 (4%) | 0% | 0 | Common Stock | |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 91,399 | 461,777 (3%) | 0% | 0 | Common Stock | |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.92 per share. | 12 Feb 2025 | 7,799 | 514,910 (4%) | 0% | 58.9 | 459,517 | Common Stock |
| Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.92 per share. | 12 Feb 2025 | 1,426 | 101,913 (0%) | 0% | 58.9 | 84,020 | Common Stock |
| Ori Gutwerg | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 10,444 | 103,339 (0%) | 0% | 0 | Common Stock | |
| Ori Gutwerg | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 15,668 | 92,895 (0%) | 0% | 0 | Common Stock | |
| Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.92 per share. | 12 Feb 2025 | 1,167 | 100,746 (0%) | 0% | 58.9 | 68,760 | Common Stock |
| Stephen P. Carey | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 16,538 | 195,814 (1%) | 0% | 0 | Common Stock | |
| Stephen P. Carey | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.92 per share. | 12 Feb 2025 | 1,730 | 194,084 (1%) | 0% | 58.9 | 101,932 | Common Stock |
| Stephen P. Carey | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 24,808 | 179,276 (1%) | 0% | 0 | Common Stock | |
| Thomas Rowland | SVP, HEAD - ESTABLISHED BRANDS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 7,834 | 41,452 (0%) | 0% | 0 | Common Stock | |
| Thomas Rowland | SVP, HEAD - ESTABLISHED BRANDS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 5,222 | 46,674 (0%) | 0% | 0 | Common Stock | |
| Thomas Rowland | SVP, HEAD - ESTABLISHED BRANDS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.92 per share. | 12 Feb 2025 | 582 | 46,092 (0%) | 0% | 58.9 | 34,291 | Common Stock |
| Christopher Mutz | HEAD OF RARE DISEASE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.92 per share. | 12 Feb 2025 | 1,473 | 116,650 (0%) | 0% | 58.9 | 86,789 | Common Stock |
| Krista Davis | SVP, CHIEF HR OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 8,704 | 70,820 (0%) | 0% | 0 | Common Stock | |
| Krista Davis | SVP, CHIEF HR OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.92 per share. | 12 Feb 2025 | 1,196 | 69,624 (0%) | 0% | 58.9 | 70,468 | Common Stock |
| Krista Davis | SVP, CHIEF HR OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 13,057 | 62,116 (0%) | 0% | 0 | Common Stock | |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 16,974 | 72,562 (0%) | 0% | 0 | Common Stock | |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 11,316 | 83,878 (0%) | 0% | 0 | Common Stock | |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale of securities on an exchange or to another person at price $ 59.54 per share. | 12 Feb 2025 | 400 | 83,478 (0%) | 0% | 59.5 | 23,816 | Common Stock |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.92 per share. | 12 Feb 2025 | 1,434 | 82,044 (0%) | 0% | 58.9 | 84,491 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 9,574 | 92,588 (0%) | 0% | 0 | Common Stock | |
| Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 9,574 | 73,615 (0%) | 0% | 0 | Common Stock | |
| Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 14,362 | 64,041 (0%) | 0% | 0 | Common Stock | |
| Christopher Mutz | HEAD OF RARE DISEASE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 24,808 | 101,585 (0%) | 0% | 0 | Common Stock | |
| Christopher Mutz | HEAD OF RARE DISEASE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.92 per share. | 12 Feb 2025 | 1,184 | 115,466 (0%) | 0% | 58.9 | 69,761 | Common Stock |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale of securities on an exchange or to another person at price $ 53.92 per share. | 13 Jan 2025 | 400 | 55,588 (0%) | 0% | 53.9 | 21,568 | Common Stock |
| Carey Stephen P. | SVP & CFO | Sale of securities on an exchange or to another person at price $ 55.79 per share. | 17 Dec 2024 | 7,500 | 154,468 (1%) | 0% | 55.8 | 418,425 | Common Stock |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale of securities on an exchange or to another person at price $ 56.24 per share. | 13 Dec 2024 | 250 | 55,988 (0%) | 0% | 56.2 | 14,060 | Common Stock |
| Krista Davis | SVP, CHIEF HR OFFICER | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 11 Dec 2024 | 1,000 | 49,059 (0%) | 0% | 60 | 60,000 | Common Stock |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2024 | 30,000 | 138,027 | - | - | Stock Option (right to buy) | |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 57.95 per share. | 26 Nov 2024 | 30,000 | 373,859 (3%) | 0% | 58.0 | 1,738,500 | Common Stock |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.00 per share. | 26 Nov 2024 | 30,000 | 403,859 (3%) | 0% | 29 | 870,000 | Common Stock |
| Lalwani Nikhil | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 58.30 per share. | 26 Nov 2024 | 3,481 | 370,378 (3%) | 0% | 58.3 | 202,942 | Common Stock |
| Christopher Mutz | HEAD OF RARE DISEASE | Sale of securities on an exchange or to another person at price $ 57.70 per share. | 15 Nov 2024 | 6,500 | 76,777 (0%) | 0% | 57.7 | 375,050 | Common Stock |
| Thomas Rowland | SVP, HEAD - ESTABLISHED BRANDS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.58 per share. | 15 Nov 2024 | 867 | 33,169 (0%) | 0% | 56.6 | 49,055 | Common Stock |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale of securities on an exchange or to another person at price $ 61.36 per share. | 13 Nov 2024 | 250 | 56,238 (0%) | 0% | 61.4 | 15,340 | Common Stock |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale of securities on an exchange or to another person at price $ 57.19 per share. | 14 Oct 2024 | 250 | 56,488 (0%) | 0% | 57.2 | 14,298 | Common Stock |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale of securities on an exchange or to another person at price $ 56.82 per share. | 13 Sep 2024 | 250 | 56,738 (0%) | 0% | 56.8 | 14,205 | Common Stock |
| Krista Davis | SVP, CHIEF HR OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.15 per share. | 12 Sep 2024 | 1,486 | 50,059 (0%) | 0% | 56.2 | 83,439 | Common Stock |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.51 per share. | 08 Sep 2024 | 3,646 | 373,859 (3%) | 0% | 60.5 | 220,619 | Common Stock |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale of securities on an exchange or to another person at price $ 59.62 per share. | 13 Aug 2024 | 250 | 56,988 (0%) | 0% | 59.6 | 14,905 | Common Stock |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.35 per share. | 18 Jul 2024 | 1,743 | 57,238 (0%) | 0% | 61.3 | 106,933 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 62.00 per share. | 18 Jul 2024 | 2,743 | 632,620 (5%) | 0% | 62 | 170,066 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 63.38 per share. | 15 Jul 2024 | 11,000 | 671,620 (5%) | 0% | 63.4 | 697,180 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 64.27 per share. | 15 Jul 2024 | 22,000 | 649,620 (5%) | 0% | 64.3 | 1,413,940 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 63.16 per share. | 15 Jul 2024 | 14,257 | 635,363 (5%) | 0% | 63.2 | 900,472 | Common Stock |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale of securities on an exchange or to another person at price $ 64.91 per share. | 12 Jul 2024 | 250 | 58,981 (0%) | 0% | 64.9 | 16,228 | Common Stock |
| Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 63.44 per share. | 01 Jul 2024 | 20,000 | 193,226 (1%) | 0% | 63.4 | 1,268,800 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 58.90 per share. | 21 Jun 2024 | 20,000 | 682,620 (5%) | 0% | 58.9 | 1,178,000 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 61.41 per share. | 17 Jun 2024 | 7,946 | 724,674 (5%) | 0% | 61.4 | 487,964 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 59.86 per share. | 17 Jun 2024 | 11,447 | 702,620 (5%) | 0% | 59.9 | 685,217 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 60.76 per share. | 17 Jun 2024 | 10,607 | 714,067 (5%) | 0% | 60.8 | 644,481 | Common Stock |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale of securities on an exchange or to another person at price $ 63.80 per share. | 13 Jun 2024 | 250 | 59,231 (0%) | 0% | 63.8 | 15,950 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.51 per share. | 07 Jun 2024 | 7,250 | 123,616 (1%) | 0% | 49.5 | 358,948 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.06 per share. | 07 Jun 2024 | 5,300 | 128,916 (1%) | 0% | 57.1 | 302,418 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 5,300 | 0 | - | - | Stock Option (right to buy) | |
| James G. Marken | SVP OPS & PROD DEV | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 7,250 | 0 | - | - | Stock Option (right to buy) | |
| James G. Marken | SVP OPS & PROD DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.70 per share. | 07 Jun 2024 | 11,087 | 117,829 (0%) | 0% | 67.7 | 750,590 | Common Stock |
| Ori Gutwerg | SVP, GENERICS | Sale of securities on an exchange or to another person at price $ 67.00 per share. | 05 Jun 2024 | 2,985 | 77,227 (0%) | 0% | 67 | 199,995 | Common Stock |
| Stephen P. Carey | SVP & CFO | Sale of securities on an exchange or to another person at price $ 63.58 per share. | 04 Jun 2024 | 5,000 | 161,968 (1%) | 0% | 63.6 | 317,900 | Common Stock |
| Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 64.41 per share. | 03 Jun 2024 | 20,000 | 213,226 (1%) | 0% | 64.4 | 1,288,200 | Common Stock |
| Matthew J. Leonard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 4,410 | 11,993 (0%) | 0% | 0 | Common Stock | |
| Antonio R. Pera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 4,410 | 31,037 (0%) | 0% | 0 | Common Stock | |
| Jeanne Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 4,410 | 40,609 (0%) | 0% | 0 | Common Stock | |
| Renee P. Tannenbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 4,410 | 22,621 (0%) | 0% | 0 | Common Stock | |
| Patrick D. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 4,410 | 74,712 (0%) | 0% | 0 | Common Stock | |
| Thomas J. Haughey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 4,410 | 51,526 (0%) | 0% | 0 | Common Stock | |
| Christopher Mutz | HEAD OF RARE DISEASE | Sale of securities on an exchange or to another person at price $ 61.61 per share. | 21 May 2024 | 2,000 | 83,277 (0%) | 0% | 61.6 | 123,220 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 61.81 per share. | 20 May 2024 | 12,855 | 732,620 (6%) | 0% | 61.8 | 794,568 | Common Stock |
| Renee P. Tannenbaum | Director | Sale of securities on an exchange or to another person at price $ 63.87 per share. | 16 May 2024 | 2,000 | 18,211 (0%) | 0% | 63.9 | 127,740 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 63.84 per share. | 15 May 2024 | 16,459 | 751,311 (6%) | 0% | 63.8 | 1,050,743 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 65.86 per share. | 15 May 2024 | 14,850 | 767,770 (6%) | 0% | 65.9 | 978,021 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 62.09 per share. | 15 May 2024 | 5,836 | 745,475 (6%) | 0% | 62.1 | 362,357 | Common Stock |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 66.10 per share. | 14 May 2024 | 16,669 | 377,505 (3%) | 0% | 66.1 | 1,101,821 | Common Stock |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale of securities on an exchange or to another person at price $ 67.69 per share. | 13 May 2024 | 250 | 59,481 (0%) | 0% | 67.7 | 16,923 | Common Stock |
| Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 66.62 per share. | 01 May 2024 | 20,000 | 233,226 (1%) | 0% | 66.6 | 1,332,400 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 65.17 per share. | 18 Apr 2024 | 16,809 | 782,620 (6%) | 0% | 65.2 | 1,095,443 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 64.98 per share. | 18 Apr 2024 | 10,423 | 799,429 (6%) | 0% | 65.0 | 677,287 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 65.40 per share. | 15 Apr 2024 | 9,520 | 809,852 (6%) | 0% | 65.4 | 622,608 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 66.20 per share. | 15 Apr 2024 | 5,834 | 819,372 (6%) | 0% | 66.2 | 386,211 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 66.33 per share. | 15 Apr 2024 | 7,414 | 825,206 (6%) | 0% | 66.3 | 491,771 | Common Stock |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale of securities on an exchange or to another person at price $ 67.79 per share. | 12 Apr 2024 | 250 | 59,731 (0%) | 0% | 67.8 | 16,948 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.96 per share. | 10 Apr 2024 | 2,799 | 116,006 (0%) | 0% | 67.0 | 187,421 | Common Stock |
| Stephen P. Carey | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.96 per share. | 10 Apr 2024 | 4,534 | 166,968 (1%) | 0% | 67.0 | 303,597 | Common Stock |
| Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 67.25 per share. | 01 Apr 2024 | 20,000 | 253,226 (2%) | 0% | 67.3 | 1,345,000 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.58 per share. | 23 Mar 2024 | 3,653 | 118,805 (0%) | 0% | 69.6 | 254,176 | Common Stock |
| Stephen P. Carey | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.58 per share. | 23 Mar 2024 | 6,210 | 171,502 (1%) | 0% | 69.6 | 432,092 | Common Stock |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.58 per share. | 23 Mar 2024 | 17,455 | 394,174 (3%) | 0% | 69.6 | 1,214,519 | Common Stock |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale of securities on an exchange or to another person at price $ 66.54 per share. | 13 Mar 2024 | 250 | 59,981 (0%) | 0% | 66.5 | 16,635 | Common Stock |
| Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 65.81 per share. | 11 Mar 2024 | 20,000 | 273,226 (2%) | 0% | 65.8 | 1,316,200 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 67.17 per share. | 08 Mar 2024 | 10,000 | 832,620 (6%) | 0% | 67.2 | 671,700 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.71 per share. | 07 Mar 2024 | 2,034 | 122,458 (1%) | 0% | 66.7 | 135,688 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Sale of securities on an exchange or to another person at price $ 66.37 per share. | 07 Mar 2024 | 24,338 | 124,492 (1%) | 0% | 66.4 | 1,615,313 | Common Stock |
| Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.71 per share. | 07 Mar 2024 | 2,494 | 80,212 (0%) | 0% | 66.7 | 166,375 | Common Stock |
| Christopher Mutz | HEAD OF RARE DISEASE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.71 per share. | 07 Mar 2024 | 2,110 | 85,277 (0%) | 0% | 66.7 | 140,758 | Common Stock |
| Stephen P. Carey | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.71 per share. | 07 Mar 2024 | 4,216 | 185,499 (1%) | 0% | 66.7 | 281,249 | Common Stock |
| Stephen P. Carey | SVP & CFO | Sale of securities on an exchange or to another person at price $ 65.55 per share. | 07 Mar 2024 | 7,787 | 177,712 (1%) | 0% | 65.6 | 510,438 | Common Stock |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 65.52 per share. | 06 Mar 2024 | 28,965 | 444,981 (3%) | 0% | 65.5 | 1,897,787 | Common Stock |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.71 per share. | 06 Mar 2024 | 17,060 | 427,921 (3%) | 0% | 66.7 | 1,138,073 | Common Stock |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 67.13 per share. | 06 Mar 2024 | 16,292 | 411,629 (3%) | 0% | 67.1 | 1,093,682 | Common Stock |
| Christopher Mutz | HEAD OF RARE DISEASE | Sale of securities on an exchange or to another person at price $ 66.00 per share. | 05 Mar 2024 | 5,000 | 87,387 (0%) | 0% | 66 | 330,000 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 66.35 per share. | 05 Mar 2024 | 15,085 | 842,620 (6%) | 0% | 66.4 | 1,000,890 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 65.47 per share. | 05 Mar 2024 | 14,822 | 857,705 (7%) | 0% | 65.5 | 970,396 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 65.35 per share. | 05 Mar 2024 | 10,093 | 872,527 (7%) | 0% | 65.4 | 659,578 | Common Stock |
| Antonio R. Pera | Director | Sale of securities on an exchange or to another person at price $ 65.20 per share. | 04 Mar 2024 | 7,000 | 26,627 (0%) | 0% | 65.2 | 456,400 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.67 per share. | 29 Feb 2024 | 1,058 | 148,830 (1%) | 0% | 67.7 | 71,595 | Common Stock |
| Stephen P. Carey | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.67 per share. | 29 Feb 2024 | 1,914 | 189,715 (1%) | 0% | 67.7 | 129,520 | Common Stock |
| Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.67 per share. | 29 Feb 2024 | 1,570 | 82,706 (0%) | 0% | 67.7 | 106,242 | Common Stock |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.67 per share. | 29 Feb 2024 | 10,014 | 473,946 (3%) | 0% | 67.7 | 677,647 | Common Stock |
| Christopher Mutz | HEAD OF RARE DISEASE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.67 per share. | 29 Feb 2024 | 1,275 | 92,387 (0%) | 0% | 67.7 | 86,279 | Common Stock |
| Chad Gassert | SVP - CORP. DEV. & STRATEGY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.67 per share. | 29 Feb 2024 | 1,635 | 49,679 (0%) | 0% | 67.7 | 110,640 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.67 per share. | 29 Feb 2024 | 1,122 | 68,652 (0%) | 0% | 67.7 | 75,926 | Common Stock |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.67 per share. | 29 Feb 2024 | 1,173 | 60,231 (0%) | 0% | 67.7 | 79,377 | Common Stock |
| Krista Davis | SVP, CHIEF HR OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.67 per share. | 29 Feb 2024 | 1,173 | 51,545 (0%) | 0% | 67.7 | 79,377 | Common Stock |
| Christopher Mutz | HEAD OF RARE DISEASE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.55 per share. | 15 Feb 2024 | 1,261 | 93,662 (0%) | 0% | 57.6 | 72,571 | Common Stock |
| Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.55 per share. | 15 Feb 2024 | 1,244 | 84,276 (0%) | 0% | 57.5 | 71,592 | Common Stock |
| W. Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 14,763 | 51,562 (0%) | 0% | 0 | Common Stock | |
| Marken G. James | SVP OPS & PROD DEV | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 6,710 | 149,888 (1%) | 0% | 0 | Common Stock | |
| Gutwerg Ori | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 9,842 | 85,520 (0%) | 0% | 0 | Common Stock | |
| Carey Stephen P. | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 21,474 | 177,313 (1%) | 0% | 0 | Common Stock | |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 8,946 | 69,774 (0%) | 0% | 0 | Common Stock | |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 80,530 | 430,274 (3%) | 0% | 0 | Common Stock | |
| Gutwerg Ori | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 14,763 | 75,678 (0%) | 0% | 0 | Common Stock | |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 8,946 | 51,314 (0%) | 0% | 0 | Common Stock | |
| W. Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 9,842 | 61,404 (0%) | 0% | 0 | Common Stock | |
| Mutz Christopher | HEAD OF RARE DISEASE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 12,526 | 94,923 (0%) | 0% | 0 | Common Stock | |
| Krista Davis | SVP, CHIEF HR OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 8,052 | 52,718 (0%) | 0% | 0 | Common Stock | |
| Krista Davis | SVP, CHIEF HR OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 12,079 | 44,666 (0%) | 0% | 0 | Common Stock | |
| Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 13,421 | 60,828 (0%) | 0% | 0 | Common Stock | |
| Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 13,421 | 42,368 (0%) | 0% | 0 | Common Stock | |
| Christopher Mutz | HEAD OF RARE DISEASE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 18,790 | 82,397 (0%) | 0% | 0 | Common Stock | |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 53,686 | 483,960 (4%) | 0% | 0 | Common Stock | |
| James G. Marken | SVP OPS & PROD DEV | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 10,066 | 143,178 (1%) | 0% | 0 | Common Stock | |
| Carey Stephen P. | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 14,316 | 191,629 (1%) | 0% | 0 | Common Stock | |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale of securities on an exchange or to another person at price $ 56.04 per share. | 13 Feb 2024 | 250 | 36,799 (0%) | 0% | 56.0 | 14,010 | Common Stock |
| Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 56.44 per share. | 19 Jan 2024 | 15,000 | 882,620 (7%) | 0% | 56.4 | 846,600 | Common Stock |
| Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 55.57 per share. | 19 Jan 2024 | 4,524 | 903,312 (7%) | 0% | 55.6 | 251,399 | Common Stock |
| Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 55.95 per share. | 19 Jan 2024 | 5,692 | 897,620 (7%) | 0% | 55.9 | 318,467 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 55.11 per share. | 16 Jan 2024 | 10,000 | 917,620 (7%) | 0% | 55.1 | 551,100 | Common Stock |
| Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 55.30 per share. | 16 Jan 2024 | 9,784 | 907,836 (7%) | 0% | 55.3 | 541,055 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 55.63 per share. | 16 Jan 2024 | 5,000 | 927,620 (7%) | 0% | 55.6 | 278,150 | Common Stock |
| Cook W. Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sale of securities on an exchange or to another person at price $ 56.43 per share. | 12 Jan 2024 | 250 | 37,049 (0%) | 0% | 56.4 | 14,108 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 52.44 per share. | 15 Dec 2023 | 13,026 | 957,620 (7%) | 0% | 52.4 | 683,083 | Common Stock |
| Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 52.65 per share. | 15 Dec 2023 | 25,000 | 932,620 (7%) | 0% | 52.7 | 1,316,250 | Common Stock |
| Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 52.44 per share. | 15 Dec 2023 | 11,974 | 970,646 (8%) | 0% | 52.4 | 627,917 | Common Stock |
| Cook W. Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sale of securities on an exchange or to another person at price $ 49.21 per share. | 11 Dec 2023 | 250 | 37,299 (0%) | 0% | 49.2 | 12,303 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 63.06 per share. | 28 Aug 2023 | 25,000 | 1,157,620 (9%) | 0% | 63.1 | 1,576,500 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 63.37 per share. | 28 Aug 2023 | 25,000 | 1,132,620 (9%) | 0% | 63.4 | 1,584,250 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2023 | 1,667 | 0 | - | - | Stock Option (right to buy) | |
| James G. Marken | SVP OPS & PROD DEV | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.59 per share. | 23 Aug 2023 | 3,750 | 135,377 (1%) | 0% | 40.6 | 152,213 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2023 | 3,750 | 0 | - | - | Stock Option (right to buy) | |
| James G. Marken | SVP OPS & PROD DEV | Sale of securities on an exchange or to another person at price $ 63.00 per share. | 23 Aug 2023 | 3,932 | 133,112 (1%) | 0% | 63 | 247,716 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.00 per share. | 23 Aug 2023 | 1,667 | 137,044 (1%) | 0% | 33 | 55,011 | Common Stock |
| Ori Gutwerg | SVP, GENERICS | Sale of securities on an exchange or to another person at price $ 62.39 per share. | 23 Aug 2023 | 13,502 | 62,974 (0%) | 0% | 62.4 | 842,390 | Common Stock |
| Ori Gutwerg | SVP, GENERICS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2023 | 13,502 | 13,504 | - | - | Stock Option (right to buy) | |
| Ori Gutwerg | SVP, GENERICS | Sale of securities on an exchange or to another person at price $ 62.39 per share. | 23 Aug 2023 | 2,059 | 60,915 (0%) | 0% | 62.4 | 128,461 | Common Stock |
| Ori Gutwerg | SVP, GENERICS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.49 per share. | 23 Aug 2023 | 13,502 | 76,476 (0%) | 0% | 31.5 | 425,178 | Common Stock |
| Matthew J. Leonard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2023 | 7,583 | 7,583 (0%) | 0% | 0 | Common Stock | |
| Stephen P. Carey | SVP & CFO | Sale of securities on an exchange or to another person at price $ 61.37 per share. | 14 Aug 2023 | 17,639 | 155,839 (1%) | 0% | 61.4 | 1,082,505 | Common Stock |
| Antonio R. Pera | Director | Sale of securities on an exchange or to another person at price $ 60.37 per share. | 14 Aug 2023 | 3,000 | 33,627 (0%) | 0% | 60.4 | 181,110 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 61.60 per share. | 14 Aug 2023 | 22,110 | 1,182,620 (9%) | 0% | 61.6 | 1,361,976 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 61.15 per share. | 14 Aug 2023 | 27,890 | 1,204,730 (9%) | 0% | 61.2 | 1,705,474 | Common Stock |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.00 per share. | 11 Aug 2023 | 11,616 | 365,006 (3%) | 0% | 29 | 336,864 | Common Stock |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2023 | 11,616 | 168,027 | - | - | Stock Option (right to buy) | |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 61.13 per share. | 11 Aug 2023 | 11,616 | 353,390 (2%) | 0% | 61.1 | 710,086 | Common Stock |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 57.75 per share. | 11 Aug 2023 | 56,666 | 353,390 (2%) | 0% | 57.8 | 3,272,462 | Common Stock |
| Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 51.06 per share. | 01 Aug 2023 | 20,000 | 333,226 (2%) | 0% | 51.1 | 1,021,200 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 52.56 per share. | 19 Jul 2023 | 11,500 | 1,232,620 (10%) | 0% | 52.6 | 604,440 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 51.52 per share. | 19 Jul 2023 | 6,000 | 1,244,120 (10%) | 0% | 51.5 | 309,120 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 51.48 per share. | 19 Jul 2023 | 5,969 | 1,250,120 (10%) | 0% | 51.5 | 307,284 | Common Stock |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.89 per share. | 18 Jul 2023 | 1,743 | 37,799 (0%) | 0% | 51.9 | 90,444 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 50.43 per share. | 14 Jul 2023 | 10,000 | 1,272,620 (10%) | 0% | 50.4 | 504,300 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 51.84 per share. | 14 Jul 2023 | 6,700 | 1,256,089 (10%) | 0% | 51.8 | 347,328 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 51.06 per share. | 14 Jul 2023 | 9,831 | 1,262,789 (10%) | 0% | 51.1 | 501,971 | Common Stock |
| Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 53.43 per share. | 03 Jul 2023 | 20,000 | 353,226 (2%) | 0% | 53.4 | 1,068,600 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 51.93 per share. | 20 Jun 2023 | 14,657 | 32,750 (0%) | 0% | 51.9 | 761,138 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 51.38 per share. | 20 Jun 2023 | 13,500 | 7,407 (0%) | 0% | 51.4 | 693,630 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 51.95 per share. | 20 Jun 2023 | 11,843 | 20,907 (0%) | 0% | 52.0 | 615,244 | Common Stock |
| David B. Nash | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 6,865 | 38,561 (0%) | 0% | 0 | Common Stock | |
| Thomas J. Haughey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 6,865 | 47,116 (0%) | 0% | 0 | Common Stock | |
| Patrick D. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 6,865 | 70,302 (0%) | 0% | 0 | Common Stock | |
| Renee P. Tannenbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 6,865 | 20,211 (0%) | 0% | 0 | Common Stock | |
| Jeanne Thoma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 6,865 | 36,199 (0%) | 0% | 0 | Common Stock | |
| Antonio R. Pera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 6,865 | 36,627 (0%) | 0% | 0 | Common Stock | |
| James G. Marken | SVP OPS & PROD DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.50 per share. | 10 Apr 2023 | 2,289 | 131,627 (1%) | 0% | 38.5 | 88,127 | Common Stock |
| Stephen P. Carey | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.50 per share. | 10 Apr 2023 | 4,534 | 173,478 (1%) | 0% | 38.5 | 174,559 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.62 per share. | 28 Mar 2023 | 524 | 112,206 (0%) | 0% | 38.6 | 20,237 | Common Stock |
| Stephen P. Carey | SVP AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.62 per share. | 28 Mar 2023 | 1,420 | 137,486 (1%) | 0% | 38.6 | 54,840 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.82 per share. | 23 Mar 2023 | 2,452 | 112,730 (0%) | 0% | 37.8 | 92,735 | Common Stock |
| Stephen P. Carey | SVP AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.82 per share. | 23 Mar 2023 | 4,224 | 138,906 (1%) | 0% | 37.8 | 159,752 | Common Stock |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.82 per share. | 23 Mar 2023 | 17,455 | 250,840 (2%) | 0% | 37.8 | 660,148 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.23 per share. | 07 Mar 2023 | 509 | 115,182 (0%) | 0% | 44.2 | 22,513 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.23 per share. | 07 Mar 2023 | 1,951 | 115,691 (0%) | 0% | 44.2 | 86,293 | Common Stock |
| Stephen P. Carey | SVP AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.23 per share. | 07 Mar 2023 | 2,639 | 143,994 (1%) | 0% | 44.2 | 116,723 | Common Stock |
| Stephen P. Carey | SVP AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.23 per share. | 07 Mar 2023 | 864 | 143,130 (1%) | 0% | 44.2 | 38,215 | Common Stock |
| Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.23 per share. | 07 Mar 2023 | 1,756 | 34,613 (0%) | 0% | 44.2 | 77,668 | Common Stock |
| Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.23 per share. | 07 Mar 2023 | 586 | 34,027 (0%) | 0% | 44.2 | 25,919 | Common Stock |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.23 per share. | 07 Mar 2023 | 4,265 | 268,295 (2%) | 0% | 44.2 | 188,641 | Common Stock |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.23 per share. | 07 Mar 2023 | 9,397 | 272,560 (2%) | 0% | 44.2 | 415,629 | Common Stock |
| Christopher Mutz | HEAD OF RARE DISEASE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.23 per share. | 07 Mar 2023 | 1,426 | 38,136 (0%) | 0% | 44.2 | 63,072 | Common Stock |
| Christopher Mutz | HEAD OF RARE DISEASE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.23 per share. | 07 Mar 2023 | 476 | 37,660 (0%) | 0% | 44.2 | 21,053 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 13,026 | 125,232 (1%) | 0% | 0 | Common Stock | |
| James G. Marken | SVP OPS & PROD DEV | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 8,684 | 133,916 (1%) | 0% | 0 | Common Stock | |
| Stephen P. Carey | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 16,210 | 178,012 (1%) | 0% | 0 | Common Stock | |
| Stephen P. Carey | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 24,316 | 161,802 (1%) | 0% | 0 | Common Stock | |
| Ori Gutwerg | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 11,578 | 62,974 (0%) | 0% | 0 | Common Stock | |
| Ori Gutwerg | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 17,369 | 51,396 (0%) | 0% | 0 | Common Stock | |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 95,530 | 346,370 (2%) | 0% | 0 | Common Stock | |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 63,686 | 410,056 (3%) | 0% | 0 | Common Stock | |
| Christopher Mutz | HEAD OF RARE DISEASE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 17,369 | 55,029 (0%) | 0% | 0 | Common Stock | |
| Christopher Mutz | HEAD OF RARE DISEASE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 11,578 | 66,607 (0%) | 0% | 0 | Common Stock | |
| Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 17,369 | 17,369 (0%) | 0% | 0 | Common Stock | |
| Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 11,578 | 28,947 (0%) | 0% | 0 | Common Stock | |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 11,578 | 47,407 (0%) | 0% | 0 | Common Stock | |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 17,369 | 35,829 (0%) | 0% | 0 | Common Stock | |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 12,158 | 31,438 (0%) | 0% | 0 | Common Stock | |
| Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 8,104 | 39,542 (0%) | 0% | 0 | Common Stock | |
| Krista Davis | SVP, CHIEF HR OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 12,158 | 28,591 (0%) | 0% | 0 | Common Stock | |
| Krista Davis | SVP, CHIEF HR OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 8,104 | 36,695 (0%) | 0% | 0 | Common Stock | |
| Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.04 per share. | 15 Feb 2023 | 1,275 | 36,369 (0%) | 0% | 45.0 | 57,426 | Common Stock |
| Christopher Mutz | HEAD OF RARE DISEASE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.04 per share. | 15 Feb 2023 | 1,292 | 39,562 (0%) | 0% | 45.0 | 58,192 | Common Stock |
| Krista Davis | SVP, CHIEF HR OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2022 | 16,433 | 16,433 (0%) | 0% | 0 | Common Stock | |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.61 per share. | 08 Sep 2022 | 3,646 | 281,957 (2%) | 0% | 37.6 | 137,126 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Sale of securities on an exchange or to another person at price $ 37.79 per share. | 12 Aug 2022 | 5,172 | 117,642 (0%) | 0% | 37.8 | 195,464 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Sale of securities on an exchange or to another person at price $ 37.04 per share. | 12 Aug 2022 | 12,894 | 122,814 (1%) | 0% | 37.0 | 477,605 | Common Stock |
| Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2022 | 19,280 | 19,280 (0%) | 0% | 0 | Common Stock | |
| David B. Nash | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 10,049 | 31,696 (0%) | 0% | 0 | Common Stock | |
| Thomas J. Haughey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 10,049 | 40,251 (0%) | 0% | 0 | Common Stock | |
| Patrick D. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 10,049 | 63,437 (0%) | 0% | 0 | Common Stock | |
| Jeanne Thoma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 10,049 | 29,334 (0%) | 0% | 0 | Common Stock | |
| Robert E. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 10,049 | 49,021 (0%) | 0% | 0 | Common Stock | |
| James G. Marken | SVP OPS & PROD DEV | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 6,644 | 135,708 (1%) | 0% | 0 | Common Stock | |
| Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 11,291 | 146,633 (1%) | 0% | 0 | Common Stock | |
| Antonio R. Pera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 10,049 | 29,762 (0%) | 0% | 0 | Common Stock | |
| Ori Gutwerg | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 6,476 | 37,644 (0%) | 0% | 0 | Common Stock | |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 33,352 | 285,603 (2%) | 0% | 0 | Common Stock | |
| Christopher Mutz | HEAD OF RARE DISEASE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 6,476 | 40,854 (0%) | 0% | 0 | Common Stock | |
| James G. Marken | SVP OPS & PROD DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.91 per share. | 10 Apr 2022 | 1,878 | 129,064 (1%) | 0% | 29.9 | 56,171 | Common Stock |
| Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.91 per share. | 10 Apr 2022 | 4,534 | 135,342 (1%) | 0% | 29.9 | 135,612 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.69 per share. | 06 Apr 2022 | 337 | 130,942 (1%) | 0% | 29.7 | 10,006 | Common Stock |
| Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.69 per share. | 06 Apr 2022 | 912 | 139,876 (1%) | 0% | 29.7 | 27,077 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.17 per share. | 28 Mar 2022 | 524 | 131,279 (1%) | 0% | 28.2 | 14,761 | Common Stock |
| Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.17 per share. | 28 Mar 2022 | 1,420 | 140,788 (1%) | 0% | 28.2 | 40,001 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 19,934 | 131,803 (1%) | 0% | 0 | Common Stock | |
| Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 33,875 | 142,208 (1%) | 0% | 0 | Common Stock | |
| Ori Gutwerg | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 19,428 | 31,168 (0%) | 0% | 0 | Common Stock | |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 100,055 | 252,251 (2%) | 0% | 0 | Common Stock | |
| Christopher Mutz | HEAD OF RARE DISEASE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 19,428 | 34,378 (0%) | 0% | 0 | Common Stock | |
| Patrick D. Walsh | Director | Purchase of securities on an exchange or from another person at price $ 27.76 per share. | 21 Mar 2022 | 5,000 | 53,388 (0%) | 0% | 27.8 | 138,794 | Common Stock |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Purchase of securities on an exchange or from another person at price $ 27.69 per share. | 21 Mar 2022 | 7,224 | 169,650 (1%) | 0% | 27.7 | 199,997 | Common Stock |
| Renee P. Tannenbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2022 | 13,346 | 13,346 (0%) | 0% | 0 | Common Stock | |
| Chad Gassert | SVP - CORP. DEV. & STRATEGY | Purchase of securities on an exchange or from another person at price $ 27.87 per share. | 18 Mar 2022 | 5,000 | 393,226 (3%) | 0% | 27.9 | 139,343 | Common Stock |
| Chad Gassert | SVP - CORP. DEV. & STRATEGY | Purchase of securities on an exchange or from another person at price $ 27.15 per share. | 18 Mar 2022 | 5,000 | 388,226 (3%) | 0% | 27.1 | 135,744 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Purchase of securities on an exchange or from another person at price $ 27.65 per share. | 17 Mar 2022 | 5,000 | 5,000 (0%) | 0% | 27.7 | 138,252 | Common Stock |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Purchase of securities on an exchange or from another person at price $ 27.65 per share. | 17 Mar 2022 | 5,000 | 18,460 (0%) | 0% | 27.7 | 138,252 | Common Stock |
| Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.25 per share. | 15 Feb 2022 | 1,167 | 11,740 (0%) | 0% | 40.3 | 46,972 | Common Stock |
| Christopher Mutz | HEAD OF RARE DISEASE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.25 per share. | 15 Feb 2022 | 1,184 | 14,950 (0%) | 0% | 40.3 | 47,656 | Common Stock |
| Jeanne Thoma | Director | Purchase of securities on an exchange or from another person at price $ 46.47 per share. | 20 Dec 2021 | 1,072 | 17,785 (0%) | 0% | 46.5 | 49,820 | Common Stock |
| Antonio R. Pera | Director | Purchase of securities on an exchange or from another person at price $ 42.26 per share. | 07 Dec 2021 | 3,000 | 19,713 (0%) | 0% | 42.3 | 126,794 | Common Stock |
| Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 383,226 | 383,226 (3%) | 3% | - | Common Stock | |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 1,332,620 | 1,332,620 (11%) | 11% | - | Common Stock | |
| Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 13,460 | 13,460 (0%) | 0% | - | Common Stock | |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.20 per share. | 08 Sep 2021 | 2,577 | 162,426 (1%) | 0% | 28.2 | 72,671 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.86 per share. | 12 Apr 2021 | 1,878 | 114,321 (0%) | 0% | 31.9 | 59,833 | Common Stock |
| Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.86 per share. | 12 Apr 2021 | 3,042 | 112,500 (0%) | 0% | 31.9 | 96,918 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.69 per share. | 06 Apr 2021 | 337 | 116,199 (0%) | 0% | 33.7 | 11,354 | Common Stock |
| Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.69 per share. | 06 Apr 2021 | 612 | 115,542 (0%) | 0% | 33.7 | 20,618 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.14 per share. | 29 Mar 2021 | 278 | 116,536 (0%) | 0% | 36.1 | 10,047 | Common Stock |
| James G. Marken | SVP OPS & PROD DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.68 per share. | 29 Mar 2021 | 524 | 116,814 (0%) | 0% | 32.7 | 17,124 | Common Stock |
| Robert Schrepfer | SVP - NEW BUS DEV & SPEC SALES | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.68 per share. | 29 Mar 2021 | 5,566 | 87,477 (0%) | 0% | 32.7 | 181,897 | Common Stock |
| Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.68 per share. | 29 Mar 2021 | 953 | 116,662 (0%) | 0% | 32.7 | 31,144 | Common Stock |
| Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.14 per share. | 29 Mar 2021 | 508 | 116,154 (0%) | 0% | 36.1 | 18,359 | Common Stock |
| David B. Nash | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2021 | 9,292 | 21,647 (0%) | 0% | 0 | Common Stock | |
| Thomas Haughey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2021 | 9,292 | 27,702 (0%) | 0% | 0 | Common Stock | |
| Patrick D. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2021 | 9,292 | 48,388 (0%) | 0% | 0 | Common Stock | |
| Jeanne Thoma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2021 | 9,292 | 16,713 (0%) | 0% | 0 | Common Stock | |
| Robert E. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2021 | 9,292 | 38,972 (0%) | 0% | 0 | Common Stock | |
| James G. Marken | SVP OPS & PROD DEV | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2021 | 32,041 | 117,338 (0%) | 0% | 0 | Common Stock | |
| Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2021 | 54,470 | 117,615 (0%) | 0% | 0 | Common Stock | |
| Antonio R. Pera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2021 | 9,292 | 16,713 (0%) | 0% | 0 | Common Stock | |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2021 | 136,495 | 165,003 (1%) | 1% | 0 | Common Stock | |
| Patrick D. Walsh | Director | Purchase of securities on an exchange or from another person at price $ 32.89 per share. | 15 Mar 2021 | 4,000 | 39,096 (0%) | 0% | 32.9 | 131,555 | Common Stock |
| Ori Gutwerg | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2021 | 12,907 | 12,907 (0%) | 0% | 0 | Common Stock | |
| Ori Gutwerg | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2021 | 27,006 | 27,006 | - | - | Stock Option (right to buy) | |
| Christopher Mutz | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2021 | 33,758 | 33,758 | - | - | Stock Option (right to buy) | |
| Christopher Mutz | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2021 | 16,134 | 16,134 (0%) | 0% | 0 | Common Stock | |
| Patrick D. Walsh | Director | Purchase of securities on an exchange or from another person at price $ 25.96 per share. | 09 Nov 2020 | 5,000 | 35,096 (0%) | 0% | 26.0 | 129,800 | Common Stock |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2020 | 179,643 | 179,643 | - | - | Stock Option (right to buy) | |
| Nikhil Lalwani | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2020 | 28,508 | 28,508 (0%) | 0% | 0 | Common Stock | |
| Patrick D. Walsh | Director, CHAIRMAN, INTERIM PRES. & CEO | Purchase of securities on an exchange or from another person at price $ 30.40 per share. | 10 Aug 2020 | 3,000 | 23,096 (0%) | 0% | 30.4 | 91,200 | Common Stock |
| Patrick D. Walsh | Director, CHAIRMAN, INTERIM PRES. & CEO | Purchase of securities on an exchange or from another person at price $ 30.89 per share. | 10 Aug 2020 | 3,000 | 30,096 (0%) | 0% | 30.9 | 92,670 | Common Stock |
| Patrick D. Walsh | Director, CHAIRMAN, INTERIM PRES. & CEO | Purchase of securities on an exchange or from another person at price $ 30.98 per share. | 10 Aug 2020 | 4,000 | 27,096 (0%) | 0% | 31.0 | 123,920 | Common Stock |
| Jeanne Thoma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 16,024 | 16,024 | - | - | Stock Option (right to buy) | |
| Jeanne Thoma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 7,421 | 7,421 (0%) | 0% | 0 | Common Stock | |
| Antonio R. Pera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 7,421 | 7,421 (0%) | 0% | 0 | Common Stock | |
| Antonio R. Pera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 16,024 | 16,024 | - | - | Stock Option (right to buy) | |
| Patrick D. Walsh | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2020 | 7,050 | 20,096 (0%) | 0% | 0 | Common Stock | |
| David B. Nash | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2020 | 7,119 | 12,355 (0%) | 0% | 0 | Common Stock | |
| Thomas Haughey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2020 | 7,119 | 18,410 (0%) | 0% | 0 | Common Stock | |
| Patrick D. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2020 | 9,255 | 13,046 (0%) | 0% | 0 | Common Stock | |
| Robert E. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2020 | 7,119 | 29,680 (0%) | 0% | 0 | Common Stock | |
| James G. Marken | SVP Ops & Prod Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2020 | 24,548 | 85,297 (0%) | 0% | 0 | Common Stock | |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2020 | 39,767 | 93,043 (0%) | 0% | 0 | Common Stock | |
| Stephen P. Carey | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2020 | 39,767 | 63,145 (0%) | 0% | 0 | Common Stock | |
| Arthur S. Przybyl | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. | 06 Apr 2020 | 2,115 | 190,309 (1%) | 0% | 43.9 | 92,912 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.22 per share. | 06 Apr 2020 | 3,282 | 192,424 (1%) | 0% | 43.2 | 141,848 | Common Stock |
| James G. Marken | SVP Ops & Prod Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.22 per share. | 06 Apr 2020 | 337 | 60,893 (0%) | 0% | 43.2 | 14,565 | Common Stock |
| James G. Marken | SVP Ops & Prod Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. | 06 Apr 2020 | 144 | 60,749 (0%) | 0% | 43.9 | 6,326 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.22 per share. | 06 Apr 2020 | 666 | 53,672 (0%) | 0% | 43.2 | 28,785 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. | 06 Apr 2020 | 396 | 53,276 (0%) | 0% | 43.9 | 17,396 | Common Stock |
| Stephen P. Carey | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.22 per share. | 06 Apr 2020 | 612 | 23,378 (0%) | 0% | 43.2 | 26,451 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.74 per share. | 28 Mar 2020 | 2,679 | 195,706 (1%) | 0% | 40.7 | 109,142 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.76 per share. | 28 Mar 2020 | 4,204 | 198,385 (1%) | 0% | 37.8 | 158,743 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.74 per share. | 28 Mar 2020 | 552 | 54,338 (0%) | 0% | 40.7 | 22,488 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.76 per share. | 28 Mar 2020 | 1,037 | 54,890 (0%) | 0% | 37.8 | 39,157 | Common Stock |
| Stephen P. Carey | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.76 per share. | 28 Mar 2020 | 953 | 24,497 (0%) | 0% | 37.8 | 35,985 | Common Stock |
| Stephen P. Carey | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.74 per share. | 28 Mar 2020 | 507 | 23,990 (0%) | 0% | 40.7 | 20,655 | Common Stock |
| Thomas Haughey | Director | Purchase of securities on an exchange or from another person at price $ 45.05 per share. | 03 Mar 2020 | 3,000 | 11,291 (0%) | 0% | 45.1 | 135,150 | Common Stock |
| Thomas Haughey | Director | Purchase of securities on an exchange or from another person at price $ 45.18 per share. | 03 Mar 2020 | 2,000 | 8,291 (0%) | 0% | 45.2 | 90,360 | Common Stock |
| David B. Nash | None | Purchase of securities on an exchange or from another person at price $ 68.76 per share. | 24 May 2019 | 1,445 | 5,236 (0%) | 0% | 68.8 | 99,358 | Common Stock |
| James G. Marken | SVP Ops & Prod Dev | Sale of securities on an exchange or to another person at price $ 70.67 per share. | 17 May 2019 | 8,907 | 61,230 (0%) | 0% | 70.7 | 629,458 | Common Stock |
| Robert E. Brown | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.36 per share. | 16 May 2019 | 1,042 | 21,394 (0%) | 0% | 6.4 | 6,627 | Common Stock |
| Robert E. Brown | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2019 | 1,167 | 0 | - | - | Stock Option | |
| Robert E. Brown | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2019 | 1,042 | 0 | - | - | Stock Option | |
| Robert E. Brown | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.00 per share. | 16 May 2019 | 1,167 | 22,561 (0%) | 0% | 33 | 38,511 | Common Stock |
| Thomas Haughey | None | Purchase of securities on an exchange or from another person at price $ 69.30 per share. | 15 May 2019 | 2,500 | 6,291 (0%) | 0% | 69.3 | 173,240 | Common Stock |
| James G. Marken | SVP Ops & Prod Dev | Sale of securities on an exchange or to another person at price $ 70.31 per share. | 14 May 2019 | 4,917 | 70,137 (0%) | 0% | 70.3 | 345,714 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Sale of securities on an exchange or to another person at price $ 71.13 per share. | 13 May 2019 | 2,409 | 55,927 (0%) | 0% | 71.1 | 171,352 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.60 per share. | 16 Apr 2019 | 1,692 | 232,589 (1%) | 0% | 68.6 | 116,071 | Common Stock |
| James G. Marken | SVP Ops & Prod Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.60 per share. | 16 Apr 2019 | 115 | 75,054 (0%) | 0% | 68.6 | 7,889 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.60 per share. | 16 Apr 2019 | 360 | 58,336 (0%) | 0% | 68.6 | 24,696 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.50 per share. | 06 Apr 2019 | 3,282 | 236,396 (1%) | 0% | 70.5 | 231,381 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.50 per share. | 06 Apr 2019 | 2,115 | 234,281 (1%) | 0% | 70.5 | 149,108 | Common Stock |
| James G. Marken | SVP Ops & Prod Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.50 per share. | 06 Apr 2019 | 144 | 75,169 (0%) | 0% | 70.5 | 10,152 | Common Stock |
| James G. Marken | SVP Ops & Prod Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.50 per share. | 06 Apr 2019 | 337 | 75,313 (0%) | 0% | 70.5 | 23,759 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.50 per share. | 06 Apr 2019 | 392 | 58,696 (0%) | 0% | 70.5 | 27,636 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.50 per share. | 06 Apr 2019 | 659 | 59,088 (0%) | 0% | 70.5 | 46,460 | Common Stock |
| Stephen P. Carey | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.50 per share. | 06 Apr 2019 | 612 | 25,450 (0%) | 0% | 70.5 | 43,146 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.54 per share. | 31 Mar 2019 | 2,678 | 239,678 (1%) | 0% | 70.5 | 188,906 | Common Stock |
| James G. Marken | SVP Ops & Prod Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.54 per share. | 31 Mar 2019 | 278 | 75,650 (0%) | 0% | 70.5 | 19,610 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.54 per share. | 31 Mar 2019 | 546 | 59,747 (0%) | 0% | 70.5 | 38,515 | Common Stock |
| Stephen P. Carey | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.54 per share. | 31 Mar 2019 | 507 | 26,062 (0%) | 0% | 70.5 | 35,764 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 37,280 | 242,356 (2%) | 0% | 0 | Common Stock | |
| Arthur S. Przybyl | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 45,106 | 45,106 | - | - | Stock Options | |
| David B. Nash | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 1,991 | 3,791 (0%) | 0% | 0 | Common Stock | |
| David B. Nash | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 2,409 | 2,409 | - | - | Stock Options | |
| Thomas Haughey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 2,409 | 2,409 | - | - | Stock Options | |
| Thomas Haughey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 1,991 | 3,791 (0%) | 0% | 0 | Common Stock | |
| Patrick D. Walsh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 2,409 | 2,409 | - | - | Stock Options | |
| Patrick D. Walsh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 1,991 | 3,791 (0%) | 0% | 0 | Common Stock | |
| Robert E. Brown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 2,584 | 20,352 (0%) | 0% | 0 | Common Stock | |
| Robert E. Brown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 3,127 | 3,127 | - | - | Stock Options | |
| Thomas A. Penn | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 1,991 | 14,301 (0%) | 0% | 0 | Common Stock | |
| Thomas A. Penn | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 2,409 | 2,409 | - | - | Stock Options | |
| James G. Marken | SVP Ops & Prod Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 8,285 | 8,285 | - | - | Stock Options | |
| James G. Marken | SVP Ops & Prod Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 6,848 | 75,928 (0%) | 0% | 0 | Common Stock | |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 15,064 | 15,064 | - | - | Stock Options | |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 12,451 | 60,293 (0%) | 0% | 0 | Common Stock | |
| Stephen P. Carey | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 15,064 | 15,064 | - | - | Stock Options | |
| Stephen P. Carey | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 12,451 | 26,569 (0%) | 0% | 0 | Common Stock | |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Sale of securities on an exchange or to another person at price $ 64.44 per share. | 12 Mar 2019 | 5,642 | 47,842 (0%) | 0% | 64.4 | 363,578 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2019 | 4,651 | 3,846 | - | - | Option to Purchase | |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2019 | 1,503 | 8,497 | - | - | Option to Purchase | |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2019 | 5,642 | 608 | - | - | Option to Purchase | |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Sale of securities on an exchange or to another person at price $ 64.43 per share. | 12 Mar 2019 | 4,651 | 47,842 (0%) | 0% | 64.4 | 299,646 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.00 per share. | 12 Mar 2019 | 4,651 | 52,493 (0%) | 0% | 33 | 153,483 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Sale of securities on an exchange or to another person at price $ 64.50 per share. | 12 Mar 2019 | 1,503 | 47,842 (0%) | 0% | 64.5 | 96,944 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.00 per share. | 12 Mar 2019 | 1,503 | 49,345 (0%) | 0% | 33 | 49,599 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.76 per share. | 12 Mar 2019 | 5,642 | 53,484 (0%) | 0% | 28.8 | 162,264 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2018 | 2,180 | 205,076 (1%) | 0% | 0 | Common Stock | |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.60 per share. | 11 Sep 2018 | 28,688 | 47,842 (0%) | 0% | 6.6 | 189,341 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2018 | 28,688 | 0 | - | - | Option to Purchase | |
| David B. Nash | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2018 | 2,225 | 2,225 | - | - | Stock Options | |
| David B. Nash | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2018 | 1,800 | 1,800 (0%) | 0% | 0 | Common Stock | |
| Thomas Haughey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2018 | 2,225 | 2,225 | - | - | Stock Options | |
| Thomas Haughey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2018 | 1,800 | 1,800 (0%) | 0% | 0 | Common Stock | |
| Patrick D. Walsh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2018 | 1,800 | 1,800 (0%) | 0% | 0 | Common Stock | |
| Patrick D. Walsh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2018 | 2,225 | 2,225 | - | - | Stock Options | |
| Robert E. Brown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2018 | 1,200 | 17,768 (0%) | 0% | 0 | Common Stock | |
| Robert E. Brown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2018 | 2,575 | 2,575 | - | - | Stock Options | |
| Thomas A. Penn | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2018 | 1,475 | 1,475 | - | - | Stock Options | |
| Thomas A. Penn | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2018 | 1,200 | 12,310 (0%) | 0% | 0 | Common Stock | |
| Arthur S. Przybyl | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.88 per share. | 22 May 2018 | 1,375 | 207,256 (1%) | 0% | 61.9 | 85,085 | Common Stock |
| James G. Marken | SVP Ops & Prod Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.88 per share. | 22 May 2018 | 253 | 69,080 (0%) | 0% | 61.9 | 15,656 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.88 per share. | 22 May 2018 | 600 | 19,154 (0%) | 0% | 61.9 | 37,128 | Common Stock |
| Tracy L. Marshbanks | None | Sale of securities on an exchange or to another person at price $ 62.40 per share. | 14 May 2018 | 25,706 | 349,934 (2%) | 0% | 62.4 | 1,604,054 | Common Stock |
| Tracy L. Marshbanks | None | Sale of securities on an exchange or to another person at price $ 62.05 per share. | 14 May 2018 | 7,024 | 375,640 (3%) | 0% | 62.0 | 435,839 | Common Stock |
| Tracy L. Marshbanks | None | Sale of securities on an exchange or to another person at price $ 62.35 per share. | 14 May 2018 | 5,506 | 382,664 (3%) | 0% | 62.3 | 343,299 | Common Stock |
| Tracy L. Marshbanks | None | Sale of securities on an exchange or to another person at price $ 62.05 per share. | 09 May 2018 | 20,517 | 430,084 (3%) | 0% | 62.1 | 1,273,080 | Common Stock |
| Tracy L. Marshbanks | None | Sale of securities on an exchange or to another person at price $ 62.03 per share. | 09 May 2018 | 24,229 | 388,170 (3%) | 0% | 62.0 | 1,502,925 | Common Stock |
| Tracy L. Marshbanks | None | Sale of securities on an exchange or to another person at price $ 62.14 per share. | 09 May 2018 | 17,685 | 412,399 (3%) | 0% | 62.1 | 1,098,946 | Common Stock |
| Tracy L. Marshbanks | None | Sale of securities on an exchange or to another person at price $ 62.09 per share. | 18 Apr 2018 | 33,200 | 450,601 (3%) | 0% | 62.1 | 2,061,388 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.21 per share. | 16 Apr 2018 | 1,611 | 208,631 (1%) | 0% | 60.2 | 96,998 | Common Stock |
| James G. Marken | SVP Ops & Prod Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.21 per share. | 16 Apr 2018 | 115 | 69,333 (0%) | 0% | 60.2 | 6,924 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.21 per share. | 16 Apr 2018 | 247 | 19,754 (0%) | 0% | 60.2 | 14,872 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.06 per share. | 06 Apr 2018 | 2,014 | 210,242 (1%) | 0% | 57.1 | 114,919 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2018 | 29,100 | 212,256 (1%) | 0% | 0 | Common Stock | |
| Arthur S. Przybyl | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2018 | 35,200 | 35,200 | - | - | Stock Options | |
| James G. Marken | SVP Ops & Prod Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2018 | 5,300 | 5,300 | - | - | Stock Options | |
| James G. Marken | SVP Ops & Prod Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2018 | 4,400 | 69,592 (0%) | 0% | 0 | Common Stock | |
| James G. Marken | SVP Ops & Prod Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.06 per share. | 06 Apr 2018 | 144 | 69,448 (0%) | 0% | 57.1 | 8,217 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2018 | 8,000 | 20,392 (0%) | 0% | 0 | Common Stock | |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2018 | 9,600 | 9,600 | - | - | Stock Options | |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.06 per share. | 06 Apr 2018 | 391 | 20,001 (0%) | 0% | 57.1 | 22,310 | Common Stock |
| Stephen P. Carey | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2018 | 9,600 | 9,600 | - | - | Stock Options | |
| Stephen P. Carey | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2018 | 8,000 | 14,118 (0%) | 0% | 0 | Common Stock | |
| Arthur S. Przybyl | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.22 per share. | 31 Mar 2018 | 2,550 | 183,156 (1%) | 0% | 58.2 | 148,461 | Common Stock |
| James G. Marken | SVP Ops & Prod Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.22 per share. | 31 Mar 2018 | 278 | 65,192 (0%) | 0% | 58.2 | 16,185 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.22 per share. | 31 Mar 2018 | 546 | 12,392 (0%) | 0% | 58.2 | 31,788 | Common Stock |
| Stephen P. Carey | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.22 per share. | 31 Mar 2018 | 507 | 6,118 (0%) | 0% | 58.2 | 29,518 | Common Stock |
| Fred Holubow | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2018 | 2,000 | 1,333 | - | - | Stock Options | |
| Fred Holubow | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2018 | 2,000 | 14,811 (0%) | 0% | 0 | Common Stock | |
| Arthur S. Przybyl | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2018 | 6,375 | 0 | - | - | Stock Options | |
| Arthur S. Przybyl | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 63.51 per share. | 18 Mar 2018 | 2,823 | 205,076 (1%) | 0% | 63.5 | 179,289 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2018 | 2,823 | 35,625 | - | - | Stock Options | |
| Arthur S. Przybyl | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 63.53 per share. | 18 Mar 2018 | 24,802 | 205,076 (1%) | 0% | 63.5 | 1,575,671 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2018 | 9,052 | 38,448 | - | - | Stock Options | |
| Arthur S. Przybyl | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2018 | 9,375 | 18,750 | - | - | Stock Options | |
| Daniel Raynor | None | Sale of securities on an exchange or to another person at price $ 60.62 per share. | 15 Mar 2018 | 5,313 | 289,003 (2%) | 0% | 60.6 | 322,074 | Common Stock |
| Daniel Raynor | None | Sale of securities on an exchange or to another person at price $ 61.50 per share. | 15 Mar 2018 | 1,902 | 294,316 (2%) | 0% | 61.5 | 116,973 | Common Stock |
| Tracy L. Marshbanks | None | Sale of securities on an exchange or to another person at price $ 63.10 per share. | 14 Mar 2018 | 1,912 | 483,801 (4%) | 0% | 63.1 | 120,647 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 62.03 per share. | 12 Mar 2018 | 10,000 | 185,706 (1%) | 0% | 62.0 | 620,300 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 62.63 per share. | 12 Mar 2018 | 6,525 | 195,706 (1%) | 0% | 62.6 | 408,661 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 61.52 per share. | 12 Mar 2018 | 23,475 | 202,231 (1%) | 0% | 61.5 | 1,444,182 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.36 per share. | 12 Mar 2018 | 15,723 | 225,706 (1%) | 0% | 6.4 | 99,998 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2018 | 15,723 | 0 | - | - | Stock Option | |
| Daniel Raynor | None | Sale of securities on an exchange or to another person at price $ 62.59 per share. | 12 Mar 2018 | 4,117 | 298,137 (2%) | 0% | 62.6 | 257,683 | Common Stock |
| Daniel Raynor | None | Sale of securities on an exchange or to another person at price $ 61.81 per share. | 12 Mar 2018 | 14,000 | 302,254 (2%) | 0% | 61.8 | 865,340 | Common Stock |
| Daniel Raynor | None | Sale of securities on an exchange or to another person at price $ 62.88 per share. | 12 Mar 2018 | 7,928 | 316,254 (2%) | 0% | 62.9 | 498,513 | Common Stock |
| Daniel Raynor | None | Sale of securities on an exchange or to another person at price $ 62.02 per share. | 12 Mar 2018 | 1,919 | 296,218 (2%) | 0% | 62.0 | 119,016 | Common Stock |
| Tracy L. Marshbanks | None | Sale of securities on an exchange or to another person at price $ 63.01 per share. | 08 Mar 2018 | 36,561 | 497,982 (4%) | 0% | 63.0 | 2,303,709 | Common Stock |
| Tracy L. Marshbanks | None | Sale of securities on an exchange or to another person at price $ 63.08 per share. | 08 Mar 2018 | 15,391 | 534,543 (4%) | 0% | 63.1 | 970,864 | Common Stock |
| Tracy L. Marshbanks | None | Sale of securities on an exchange or to another person at price $ 63.03 per share. | 08 Mar 2018 | 12,269 | 485,713 (4%) | 0% | 63.0 | 773,315 | Common Stock |
| James G. Marken | SVP Ops & Prod Dev | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.00 per share. | 05 Mar 2018 | 3,208 | 69,647 (0%) | 0% | 33 | 105,864 | Common Stock |
| James G. Marken | SVP Ops & Prod Dev | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.36 per share. | 05 Mar 2018 | 14,793 | 66,439 (0%) | 0% | 6.4 | 94,083 | Common Stock |
| James G. Marken | SVP Ops & Prod Dev | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2018 | 14,793 | 0 | - | - | Stock Options | |
| James G. Marken | SVP Ops & Prod Dev | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2018 | 3,208 | 1,667 | - | - | Stock Options | |
| James G. Marken | SVP Ops & Prod Dev | Sale of securities on an exchange or to another person at price $ 61.92 per share. | 05 Mar 2018 | 4,177 | 65,470 (0%) | 0% | 61.9 | 258,640 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2018 | 6,375 | 6,375 | - | - | Stock Option | |
| Arthur S. Przybyl | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2018 | 8,236 | 15,723 | - | - | Stock Option | |
| Arthur S. Przybyl | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 62.17 per share. | 01 Mar 2018 | 4,260 | 209,983 (1%) | 0% | 62.2 | 264,844 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 61.62 per share. | 01 Mar 2018 | 8,400 | 214,243 (1%) | 0% | 61.6 | 517,608 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2018 | 9,375 | 28,125 | - | - | Stock Option | |
| Arthur S. Przybyl | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 60.59 per share. | 01 Mar 2018 | 11,326 | 222,643 (1%) | 0% | 60.6 | 686,242 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.36 per share. | 01 Mar 2018 | 8,236 | 233,969 (2%) | 0% | 6.4 | 52,381 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.00 per share. | 01 Mar 2018 | 6,375 | 225,733 (1%) | 0% | 33 | 210,375 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.59 per share. | 01 Mar 2018 | 9,375 | 219,358 (1%) | 0% | 40.6 | 380,531 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Sale of securities on an exchange or to another person at price $ 61.64 per share. | 01 Mar 2018 | 10,800 | 25,292 (0%) | 0% | 61.6 | 665,712 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.76 per share. | 01 Mar 2018 | 18,750 | 41,590 (0%) | 0% | 28.8 | 539,250 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2018 | 18,750 | 6,250 | - | - | Stock Option | |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Sale of securities on an exchange or to another person at price $ 63.07 per share. | 01 Mar 2018 | 400 | 12,938 (0%) | 0% | 63.1 | 25,228 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Sale of securities on an exchange or to another person at price $ 62.25 per share. | 01 Mar 2018 | 11,954 | 13,338 (0%) | 0% | 62.3 | 744,137 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Sale of securities on an exchange or to another person at price $ 60.33 per share. | 01 Mar 2018 | 5,498 | 36,092 (0%) | 0% | 60.3 | 331,694 | Common Stock |
| Arthur S. Przybyl | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2017 | 850 | 209,983 (1%) | 0% | 0 | Common Stock | |
| Arthur S. Przybyl | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.01 per share. | 22 May 2017 | 991 | 210,833 (1%) | 0% | 47.0 | 46,587 | Common Stock |
| James G. Marken | SVP Ops & Prod Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.01 per share. | 22 May 2017 | 278 | 51,549 (0%) | 0% | 47.0 | 13,069 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.01 per share. | 22 May 2017 | 450 | 22,840 (0%) | 0% | 47.0 | 21,155 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.22 per share. | 17 Apr 2017 | 1,161 | 211,824 (1%) | 0% | 51.2 | 59,466 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.22 per share. | 17 Apr 2017 | 270 | 23,290 (0%) | 0% | 51.2 | 13,829 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.24 per share. | 07 Apr 2017 | 1,451 | 212,985 (1%) | 0% | 51.2 | 74,349 | Common Stock |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.24 per share. | 07 Apr 2017 | 427 | 23,560 (0%) | 0% | 51.2 | 21,879 | Common Stock |
| Arthur S. Przybyl | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 23,750 | 214,436 (1%) | 0% | 0 | Common Stock | |
| Arthur S. Przybyl | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Mar 2017 | 560 | 191,246 (1%) | 0% | 0 | Common Stock | |
| Arthur S. Przybyl | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 47,500 | 47,500 | - | - | Stock Options | |
| Arthur S. Przybyl | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Mar 2017 | 560 | 190,686 (1%) | 0% | 0 | Common Stock | |
| Fred Holubow | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 1,000 | 12,811 (0%) | 0% | 0 | Common Stock | |
| Fred Holubow | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 2,000 | 2,000 | - | - | Stock Options | |
| Daniel Raynor | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 2,000 | 2,000 | - | - | Stock Options | |
| Daniel Raynor | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 1,000 | 11,110 (0%) | 0% | 0 | Common Stock | |
| Tracy L. Marshbanks | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 2,000 | 2,000 | - | - | Stock Options | |
| Tracy L. Marshbanks | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 1,000 | 11,110 (0%) | 0% | 0 | Common Stock | |
| Robert E. Brown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 1,000 | 16,568 (0%) | 0% | 0 | Common Stock | |
| Robert E. Brown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 3,250 | 3,250 | - | - | Stock Options | |
| Thomas A. Penn | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 2,000 | 2,000 | - | - | Stock Options | |
| Thomas A. Penn | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 1,000 | 11,110 (0%) | 0% | 0 | Common Stock | |
| James G. Marken | SVP Ops & Prod Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 3,625 | 51,827 (0%) | 0% | 0 | Common Stock | |
| James G. Marken | SVP Ops & Prod Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 7,250 | 7,250 | - | - | Stock Options | |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 6,625 | 23,987 (0%) | 0% | 0 | Restricted Stock Units to be settled as Common Stock | |
| Robert Schrepfer | SVP - New Bus Dev & Spec Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 13,250 | 13,250 | - | - | Stock Options | |
| Stephen P. Carey | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 13,250 | 13,250 | - | - | Stock Options | |
| Stephen P. Carey | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 6,625 | 6,625 (0%) | 0% | 0 | Common Stock | |
| Robert E. Brown | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2016 | 2,333 | 1,167 | - | - | Option to Purchase | |
| Robert E. Brown | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2016 | 3,125 | 1,042 | - | - | Option to Purchase | |
| Robert E. Brown | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2016 | 2,333 | 15,568 | - | - | Common Stock |